跳至主要内容
临床试验/NCT04912661
NCT04912661已完成不适用

Iron and Vaccine-preventable Viral Disease - an Experimental Study

Swiss Federal Institute of Technology1 个研究点 分布在 1 个国家目标入组 121 人开始时间: 2021年5月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
121
试验地点
1
主要终点
Antibody avidity Index

研究概览

简要总结

Vaccines often underperform in Africa compared to high-income countries. Why vaccines do not work as well in Africa remains uncertain. Malnutrition likely plays a role. Our study objective is to assess whether iron deficiency anaemia in young women impairs their immune response to viral vaccines, and whether iron treatment improves their response.

详细描述

Group 1 (immediate iron treatment) will receive iron treatment before vaccination. Women in both groups will receive two intramuscular vaccines (influenza and yellow fever). Vaccine response will be measured 28 and 56 days after vaccine administration in both groups. Group 2 (delayed iron treatment) will receive iron treatment at study end.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-55 years old
  • Zinc protoporphyrin > or equal 40 mmol/mol heme
  • hemoglobin < or equal 109 g/L
  • no malaria
  • no known HIV infection
  • no medical condition that precludes study involvement
  • no iron supplementation 1 week prior to study start
  • no recent tuberculosis infection
  • no vaccination of yellow fever or influenza prior to enrolment
  • not pregnant

排除标准

  • 未提供

研究组 & 干预措施

Immediate iron treatment

Active Comparator

intravenous iron carboxymaltose before vaccination

干预措施: Ferinject (Dietary Supplement)

No iron treatment

No Intervention

no intravenous iron carboxymaltose before vaccination

结局指标

主要结局

Antibody avidity Index

时间窗: at 63 days

percentage of antibodies that remain bound to beads

Antibody titers

时间窗: at 63 days

Seroconversion

时间窗: at 63 days

次要结局

  • Proteomics(day 63)
  • C-reactive protein(day 63)
  • retinol binding protein(day 63)
  • immune cell populations(day 63)
  • Immune cell cytokine secretion(day 35)
  • antiviral immunoglobulin G response(day 63)
  • Hemoglobin(day 63)
  • plasma zinc(day 63)
  • Transcriptomics(day 63)
  • Plasma Ferritin(day 63)
  • Transferrin saturation(day 63)
  • Transferrin receptor(day 63)
  • Alpha-glycoprotein(day 56)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicole Stoffel

PhD

Swiss Federal Institute of Technology

研究点 (1)

Loading locations...

相似试验